Recent studies have shown that semaglutide, a GLP-1 receptor agonist, significantly aids in weight loss
Antioxidant protection: GHK-Cu peptides neutralize harmful molecules that can age skin prematurely
We emphasize a holistic approach, combining this medication with a healthy diet and regular physical activity to ensure the best outcomes for our patients
Check sources
NICE recommends GLP-1 agonists for weight management in specific circumstances: for adults with at least one weight-related comorbidity and a BMI of 35 kg/m or above (or 32.5 kg/m or above for people from South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean backgrounds)
The oral formulation could provide a significant advantage over injectable alternatives, especially for patients who may have difficulty with injections or prefer non-injection-based treatments